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increased use of arteries as a bypass graft (eg, thoracic
arteries, gastroepiploic artery, and radial artery),6,7 vein
grafts still are necessary in most patients, although they
are prone to less favorable patency rates.
T he patency rates of human vein grafts after coronaryartery bypass grafting are less favorable than those
of selected arterial grafts,1,2 although the results of fol-
low-up studies remain unequivocal.3-5 Despite the
Background: Patency of vein grafts in coronary artery bypass grafting proce-
dures is generally less favorable than those of selected arterial grafts.
However, vein grafts still are needed in cardiac operations. It would be desir-
able to find measures to improve the patency of vein grafts next to antithrom-
botic regimens. Animal studies demonstrated that arterial pressure induces
overdistention of the thin-walled vein grafts and that prevention of this
overdistention with extravascular support ameliorates the arterialization
process with, subsequently, more favorable patency. To evaluate whether
perivenous stenting of the rather muscular human vein grafts is also benefi-
cial, we designed an in vitro model to study the early effects of perivenous
support in human vein grafts.
Methods: Seven paired segments of human vein graft obtained during coro-
nary artery bypass grafting procedures were placed in a perfusion circuit and
perfused simultaneously with autologous whole blood, with a pressure of 60
mm Hg (nonpulsatile flow). After 30 minutes of perfusion, one segment, and
after 60 minutes of perfusion, the remaining segment were taken for histo-
logic and immunohistochemical examination. In the next experiments 7 seg-
ments of human vein graft were placed in the circuit and supported with a
polytetrafluoroethylene graft to prevent overdistention with 7 unstented seg-
ments as controls.
Results: In unsupported vein grafts perfused with autologous blood under a
pressure of 60 mm Hg, a complete de-endothelialization was shown after 1
hour of perfusion. In the study vein grafts, with a perivenous polytetrafluo-
roethylene graft preventing overdistention (n = 7), the endothelium remained
intact. Electron microscopic investigation of the media showed severe dam-
age in the circular smooth muscle layer in the unstented group, whereas in
the stented group almost no injury was found.
Conclusion: In our in vitro closed-loop model, reproducible vessel wall
changes were observed in all human vein graft specimens studied. The ben-
eficial effect of perivenous support could also be established for the human
greater saphenous vein, providing a basis for clinical application. (J Thorac
Cardiovasc Surg 2001;121:290-7)
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Many efforts have been made to improve the graft
patency. Antithrombotic regimens in particular have
been thoroughly investigated,8 showing superior paten-
cy in patients receiving acetylsalicylic acid.
In different animal models (sheep,9 rabbit,10,11 and
pig12,13) graft patency could successfully be improved
by perivenous stenting of vein grafts placed in the arte-
rial circulation. These studies emphasized that, among
various other factors (preoperative structural and func-
tional status of the vein graft, surgical technical aspects,
ischemic injury, and composition of storage media),
overdistention of the vein graft by the arterial pressure
is the principal cause promoting intimal hyperplasia
and vein graft atherosclerosis.14-20 The hypothesis is
that by simply preventing overdistention of the vein
graft wall with an external jacket or stent, the vein is
protected against the destructive effect of the sudden
exposure to arterial pressure. As a consequence, the
process of structural adaptation to the arterial pressure,
arterialization, proceeds more evenly.
The acute changes and structural damage in human
vein grafts is difficult to study systematically. In post-
mortem studies Kockx and associates21 described the
acute histopathologic changes in human saphenous
vein grafts in the first week after coronary artery bypass
grafting. They found a significant loss of endothelial
cells, damage to medial smooth muscle cells, and
leukocyte infiltration of the vein graft wall. This is in
accordance with the animal studies.10,22
Here we report the early effect of nonpulsatile perfu-
sion of human vein segments in vitro with autologous
whole blood and with arterial pressure. We describe the
pathologic findings in the vein wall and the effect of
perivenous stenting during the first hour of perfusion.
Methods
Patients were included in the study after providing informed
consent. The study was approved by the local ethics committee
(January 28, 1998). Anesthesia and cardiopulmonary bypass
were performed according to the routine protocol.
In the in vitro model we use a small roller pump (Stöckert
Instrumente, Munich, Germany) with a vein irrigation set
(Bentley Laboratories Europe, Uden, The Netherlands). In the
perfusion circuit two pieces of vein graft, one externally sup-
ported with a polytetrafluoroethylene (PTFE) graft and one
without, can be perfused with nonpulsatile flow under the same
pressure the vein graft encounters in the first hour after comple-
tion of the proximal anastomosis, as well as being exposed to
comparable circulatory conditions. A Haemonetics bag
(Haemonetics Corporation, Braintree, Mass) is used as a fluid
reservoir in this experiment and filled with oxygenated blood
from the heart-lung machine but separated from the cardiopul-
monary bypass circuit (Fig 1). Two segments of the study vein
graft with a length of about 2 cm harvested by means of the no-
touch technique were placed in the circuit and perfused for 60
minutes at the most. Perfusion pressure was the same as the
pressure maintained in the patients (about 60 mm Hg) by
adjusting the flow. At no point in the harvesting procedure was
distention allowed before perfusion in the perfusion system.
Specimens for histologic and immunohistochemical examina-
tion were taken before the start of perfusion (t = 0). One seg-
ment was taken out of the circuit after 30 minutes and the other
after 60 minutes of perfusion to document possible early vessel
wall changes in time. In this way 7 segments after 30 minutes
and 7 segments after 60 minutes of perfusion were evaluated.
We also evaluated 7 study vein graft segments with and 7 with-
out a perivenous PTFE stent,* again after 60 minutes of perfu-
sion, by using the same setup. The PTFE grafts were sized for
nonrestrictive support before the vein segments were placed in
the perfusion circuit. In all cases this resulted in a 5-, 6-, or 7-
mm PTFE graft.
To evaluate the covering of the luminal surface of the study
vein grafts with endothelium with an intact barrier function,
Evans blue dye23 was added to the perfusion circuit during the
last 5 minutes of perfusion. The Evans blue dye forms a com-
plex immediately with albumin in the perfusate and stains the
parts of the vessel in which the endothelial barrier is impaired.
After perfusion, the vein grafts were divided in parts for mor-
phologic examination or electron microscopy and frozen sec-
tion. All specimens for morphologic analysis were taken some
Fig 1. Schematic drawing of perfusion model.
*Grafts provided by W. L. Gore & Associates, Inc, Flagstaff, Ariz.
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distance from either cannulation site to ensure that the seg-
ments were free of trauma caused by ligation or injury from
possible flow disturbances at the cannula tip.
Immunohistochemistry. The pieces of the vein wall were
partly fixed in formaldehyde and embedded in low melting
point paraffin wax. Parts were also stored at –196°C (liquid
nitrogen).
Transverse sections of formaldehyde-embedded tissue
samples were cut at 5 µm and were stained with hematoxylin-
eosin and elastica van Giesson stains. For immunohisto-
chemistry, endogenous peroxidase activity was blocked by
0.3% (vol/vol) H2O2 in methanol. After preincubation with
normal rabbit serum (Dakopatts A/S, Stockholm, Sweden)
for 15 minutes (1:50 phosphate-buffered saline solution
[PBS]/bovine serum albumin), the slides were incubated with
the antibody CD31 (1:40 PBS-bovine serum albumin,
Dakopatts A/S) for 60 minutes.
For formaldehyde-embedded tissue, slides, and cryostat
sections, the method of staining was an indirect immunoper-
oxidase method with peroxidase-conjugated rabbit anti-
mouse immunoglobulins (1:25 PBS/bovine serum albumin,
Dakopatts A/S). Bound peroxidase was developed with 4 mg
(wt/vol) 3,3-diaminobenzidine tetrahydrochloride and 0.02%
(vol/vol) H2O2 in PBS. The slides were counterstained with
hematoxylin-eosin and mounted.
Electron microscopy. The vein-wall pieces were fixed in
2% (vol/vol) glutaraldehyde for 30 minutes and 1.5%
(wt/vol) osmium tetroxide for 10 minutes, dehydrated with
acetone, and embedded in Epon 812 fixative. Ultrathin sec-
tions were collected on 300-mesh Formavar-coated nickel
grids. The sections were contrasted with uranyl acetate and
lead citrate and examined in a JEOL 1200 EX electron micro-
scope (JEOL AB, Sundbyberg, Sweden).
The percentage of endothelium left on the luminal surface
was estimated under light microscopy by dividing the cir-
cumference of the vein segments in 12 parts and assessing the
percentage of endothelium left in each part. The assessment
was done by 2 investigators (W.S. and H.W.M.N.) blinded as
to whether the vein graft had been stented.
Specimens for electron microscopic examination were
taken before the start of perfusion (t = 0) and after 60 minutes
of perfusion to document possible early changes in the media.
At multiple sites of each vein, electron microscopic pic-
tures were made of the whole vessel wall (from the endothe-
lial layer up to the adventitial layer). The vessel wall was
divided into 4 sections (intima, longitudinal muscle layer
media, circular muscle layer media, and adventitial layer).
Every section was assessed independently by 3 investigators
(W.S., H.W.M.N., and A.B.) according to previous criteria.24
Subsequently, a qualitative assessment was made on behalf of
the evident changes. These criteria are enumerated according
to the classification mentioned in Table I.
Statistics. Data are expressed as the mean ± SD. Groups
were compared with the Student t test.
Results
Quantifications of the vessel specimens with intact
endothelium before and after perfusion are summarized
in Fig 2. In all 14 vein graft segments, a normal
endothelial layer was observed before the start of per-
fusion. In the 14 perfused specimens a progressive de-
endothelialization of 30% to 60% was perceived after
30 minutes of perfusion, culminating in almost com-
plete de-endothelialization in 60 minutes (Fig 3). Loss
of endothelial cells was observed with hematoxylin-
eosin staining (Fig 3) and confirmed with CD31 stain-
ing (Fig 4). In 2 patients a CD31+ layer was seen at the
intraluminal side after 60 minutes of perfusion, where-
as no endothelial cells were found in hematoxylin-
eosin staining. Electron microscopic examination
showed in these specific cases a strong aggregation of
thrombocytes to a denuded subendothelial matrix (Fig
Table I. Qualitative classification of electron microscopic criteria for injury in human saphenous vein grafts
Degree of injury Cell loss Edema Fragmentation of collagen Thinning of cell structures
Severe injury Yes Yes Yes No
Slight-to-moderate injury No Yes No Yes
No injury No No No No
Only evident changes are mentioned.
Table II. Degree of injury in different vein graft wall layers
Layer Control With support Without support
Endothelial layer–internal lamina No injury No to slight injury Severe injury
Longitudinal muscle layer No injury No injury Moderate injury
Circular muscle layer No injury No injury Severe injury
Adventitial layer No injury No injury Moderate injury
The Journal of Thoracic and
Cardiovascular Surgery
Volume 121, Number 2
Stooker et al 293
5). No endothelial cells could be found in these speci-
mens. To prevent overextension of the vessel during
perfusion, 7 specimens were surrounded with a perive-
nous PTFE stent and compared with nonstented con-
trols. An almost intact layer was found after perfusion
(Fig 6), whereas the nonstented controls were devoid of
endothelial cells. Electron microscopic examination of
these vessel specimens confirmed the presence of
endothelial cells in the stented grafts.
When Evans blue–albumin complex was added to the
perfusate, the entire surface of the nonstented grafts
displayed a blue color, indicating massive leakage of
the complex into the vein wall (Fig 7, A). In the grafts
with the perivenous stents, however, no Evans blue
staining was observed, suggesting that the endothelial
layer remained intact (Fig 7, B). The zones of de-
endothelialization at the extreme ends of the vein graft
are probably caused by turbulence attributable to the tip
of the cannula protruding into the vein graft lumen.
The results of the electron microscopic study are
shown in Table II. A severe injury pattern was shown in
the endothelial layer-internal lamina layer, which is in
agreement with the results obtained from light
microscopy.
Fig 2. Endothelial coverage in vein graft specimens after dif-
ferent perfusion times. Nonstented (without support, n = 14)
and stented (with support, n = 7) vein specimens were per-
fused with whole blood, and endothelial coverage was quan-
tified as described in the “Methods” section. t = 0, Sample
before perfusion; t = 30, sample after 30 minutes of perfusion
without support; t = 60, sample after 60 minutes of perfusion
without support; t = 60 with, sample after 60 minutes of per-
fusion with perivenous support. Data are expressed as means
± SD. Groups were compared with Student t test. All groups
were significantly different, with a P value of less than .001,
except for group t = 0 compared with group t = 60 with.
Fig 3. Endothelial coverage in vein specimens perfused for
different time periods. A, Before perfusion, an intact
endothelial layer is observed (hematoxylin-eosin staining). B,
After 30 minutes of perfusion, large areas are devoid of
endothelial cells. C, After 60 minutes of perfusion, a com-
plete loss of endothelial cells is seen. Representative sections
are shown. (Original magnification, 630×.)
A
B
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There is a remarkable difference in injury seen in the
circular layer of the media, which is subjected to the
greatest strain, between the stented and the unstented
group. In the stented vein grafts no injury was found in
the smooth muscle cells of this layer, whereas in the
unstented vein graft severe injury was found.
Discussion
Our study shows that perivenous support of human
saphenous vein grafts exposed to arterial perfusion
pressure in an extracorporeal circuit filled with autolo-
gous blood protects from otherwise severe damage
caused by distention of the vein graft. This damage is
characterized by de-endothelialization and rupture of
media structures within 1 hour. The same picture was
documented in animal experiments early after implan-
tation.10,11 Therefore, benefit is to be expected also for
perivenous support of a rather muscular vein, such as
the greater saphenous vein, which is mostly used for
grafting in human subjects. Moreover, in these animal
experiments sequential time samples demonstrated that
this damage leads to an inflammatory reaction in the
first week, followed by intimal hyperplasia and media
hypertrophy, resulting in extensive fibrosis of the vein
graft wall with an irregular structure in 4 to 6 weeks.
This is in contrast to the perivenous supported grafts,
which show complete regeneration of the endothelial
layer and gradual arterialization.
The de-endothelialization or even dysfunction of the
overlying endothelium will result in adhesion and
aggregation of thrombocytes to the subintimal layer
and invasion of the media by leukocytes. By lack of
down-regulation of the endothelial growth factors,
cytokines and adhesion molecules are expressed in the
media. This inflammatory reaction after de-endothe-
lialization in the first week, as observed in both animals
Fig 4. Endothelial coverage in vein specimens visualized with CD31 staining. (Original magnification, 630×.) A,
Intact endothelium stains for CD31 at the start of perfusion. B, Absence of luminal CD31 staining after 60 minutes
of perfusion, confirming complete endothelial cell loss. Note CD31 positivity in the vas vasorum.
Fig 5. CD31 staining can reflect thrombocyte aggregation. A, Strong CD31 positivity after 60 minutes of perfu-
sion, suggesting intact endothelial layer. (Original magnification, 630×.) B, Electron microscopic photomicrograph
showing strong thrombocyte aggregation and no endothelial cells. (Original magnification, 7000×.)
A B
A B
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and human subjects,21 will promote proliferation of
smooth muscle cells and atherosclerosis, leading to
luminal obstruction. With no doubt, prevention of the
injury in the first hour will have a favorable effect on
graft wall integrity and, as a consequence, on patency
in human subjects. Additionally, when the distention
damage in the initial period is prevented by a perive-
nous support providing a more gradual adaptation to
arterial pressure, a more physiologic medial thickening
or arterialization ensues, promoting long-term patency,
as in the animal models.
Our perfusion model is designed to mimic only the
first hemodynamic and rheologic situation a venous
graft will encounter after implantation while the patient
is still undergoing bypass. Although the perfusion is
nonpulsatile continuously, which is the same as in the
clinical situation for only a short period after comple-
tion of the proximal anastomosis, we postulate that
with pulsatile flow, caused by more serious overdisten-
tion, even more severe damage is to be expected.
For perivenous support, we used a PTFE graft
because the material characteristics are not important
in the early period as long as distention by the arterial
pressure is prevented. However, we have to be aware
that for adequate remodeling of the vein graft in the
later period the material characteristics of perivenous
support have to be more carefully selected.11,25,26
Our data in the first hour of whole blood perfusion
show highly reproducible structural degradation in
human vein grafts, which is similar to that seen in ani-
mal experiments and the postmortem study in patients
by Kockx and associates.21 Furthermore, our data show
that also in the human saphenous vein, these changes
can be prevented by adequate perivenous support.
We tested the barrier function of the endothelium
with Evans blue dye. In this way an instant assessment
of the presence of an endothelial layer with an intact
barrier function in the graft is possible.
Fig 6. A, Cross section through a stented vein after 60 min-
utes of perfusion, showing an intact endothelial layer.
(Original magnification, 630×.) B, Electron microscopic pho-
tomicrograph confirms the presence of endothelial cells after
60 minutes of perfusion. (Original magnification, 7000×.) C,
Unstented control vein showing no endothelium.
Fig 7. Vascular leakage as visualized with Evans blue dye.
Evans blue dye was added to the whole blood that was per-
fused through the vein specimens. Left, Unstented graft
showing no endothelial layer. Right, Stented graft showing
intact endothelial layer. The zones of de-endothelialization at
the end of the vein graft are due to turbulence attributed to the
tip of the cannula protruding in the vein graft lumen.
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In preliminary studies we found fVIIIR.Ag/vWF
positivity in the absence of endothelial cells, albeit
more weekly. Therefore, we have chosen CD31
(platelet and endothelial cell adhesion molecule) to
depict the endothelial layer.27 In most instances this
was satisfactory, although we faced false positivity
caused by platelet aggregation in 2 specimens in the
absence of endothelial cells. Therefore, it is important
to establish the presence of endothelial cell nuclei with
hematoxylin-eosin stain also.
In this study, next to the electron microscopic confir-
mation of the beneficial effect of perivenous support on
the endothelial layer and internal lamina, a remarkable
attenuation of smooth muscle cell injury was found in
the circular muscle layer of the supported vein graft
wall. This seems to be rational because especially the
circular layer will be prone to increased strain during
overdistention. Although in the first hour of perfusion
no specific inflammatory mediators, such as early
genes or adhesion molecules, can be expected, we
found adherence of leukocytes at the denuded subinti-
mal layer in a few samples.
It is remarkable and in contrast to our findings that in
an earlier study28 no complete desquamation of
endothelium was found in nonsupported human vein
grafts that had been exposed to arterial perfusion pres-
sure in a more or less comparable circuit. The main dif-
ference compared with our setup was that in this study
Krebs solution was used as the perfusate. In prelimi-
nary experiments with Krebs solution in our model, we
could reproduce these previous findings (unpublished
results). An explanation of this observation might be
that the Krebs solution results in different flow, pres-
sure, and shear stress conditions compared with blood
perfusion. More important in explaining the complete
de-endothelialization could be the presence in blood of
activated enzymes or proteases capable of destroying
the natural endothelial cell connections. Perfusion with
autologous blood might therefore mimic the clinical
situation more accurately.
In conclusion, in our in vitro closed-loop blood per-
fusion model, reproducible vessel wall changes were
observed in the rather muscular human vein graft spec-
imens exposed to arterial pressure, showing complete
de-endothelialization and severe disruption of the cir-
cular muscle layer of the media after 60 minutes of per-
fusion. These destructive changes could be prevented
with perivenous support preventing overdistention
caused by the arterial pressure.
We thank E. K. Jansen, MD, for the statistical assessment.
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